Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Somerset, New Jersey
- Most recent report
- 6-K, filed Nov 4, 2026
- Incorporated
- N/A
- Filings on record
- 386 filings
- On EDGAR
- CIK 1801198
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 201
- 6-K Report a foreign issuer made public elsewhere Nov 4, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 15, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 13, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 25, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 15, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 14, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 18, 2026
Prospectuses and Registrations 8 of 16
- S-8 Registration statement for an employee plan Oct 7, 2026
- 424B5 Prospectus supplement for an offering Jun 18, 2026
- 424B5 Prospectus supplement for an offering Jun 17, 2026
- S-8 Registration statement for an employee plan Nov 14, 2024
- 424B5 Prospectus supplement for an offering May 8, 2023
- 424B5 Prospectus supplement for an offering Jul 27, 2022
- 424B5 Prospectus supplement for an offering Jul 25, 2022
- 424B5 Prospectus supplement for an offering Dec 17, 2021
Ownership 8 of 128
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Oct 1, 2026
- 144 Notice of a proposed sale of restricted stock Sep 29, 2026
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Sep 28, 2026
- 4 Insider reported a trade Sep 28, 2026
Other 8 of 41
- F-6EF Jun 17, 2026
- UPLOAD Comment letter from SEC staff Sep 16, 2024
- CORRESP Reply to SEC staff Sep 11, 2024
- UPLOAD Comment letter from SEC staff Sep 4, 2024
- F-3ASR Mar 19, 2024
- UPLOAD Comment letter from SEC staff Sep 15, 2023
- CORRESP Reply to SEC staff Sep 8, 2023
- UPLOAD Comment letter from SEC staff Aug 31, 2023
Everything here comes from Legend Biotech Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.